Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

Ann Oncol. 2021 Nov;32(11):1443-1444. doi: 10.1016/j.annonc.2021.07.012. Epub 2021 Jul 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Neoplasms* / drug therapy
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines